MMedication Read More Should you take GLP-1 drugs for longevity?March 15, 2026 This is, indeed, part of a wider trend of mutual support at the fringes of pharmacology, with similar…
MMedication Read More Health Ministry warns against GLP-1 drug misuse, urges reporting of side effectsMarch 7, 2026 THE Health Ministry has acknowledged growing public concern over the off-label use of GLP-1 receptor agonists, especially for…
MMedication Read More Weight loss jab users warned they could be ‘worse off than before’March 5, 2026 Wegovy and Mounjaro are approved by the NHS for weight loss use (Image: OMaltseva via Getty Images) People…
MMedication Read More Weight returns four times faster after stopping weight-loss drugsJanuary 14, 2026 When people stop taking the new generation of weight-loss drugs, they pile back the kilos four times faster…
MMedication Read More Are Sexual Side Effects Emerging With GLP-1 Agonists?November 29, 2025 Few new drugs have sparked as much interest and as many questions as GLP-1 agonists. Originally developed to…
MMedication Read More When GLP-1s Change Patients’ Libido: What to KnowSeptember 30, 2025 It’s not discussed as often as other side effects of GLP-1 receptor agonists, but one adverse effect is…
HHealth Read More Pricey Drugs Unlikely to Solve DementiaAugust 21, 2025 This transcript has been edited for clarity. Dear colleagues, I’m Christoph Diener from the faculty of medicine at…
MMedication Read More Most GLP-1 Prescriptions Miss the Mark: Are Yours?July 28, 2025 GLP-1 receptor agonists, including semaglutide, are now widely used for weight loss, offering substantial weight reduction, improved metabolic…